Shimadzu debuts two new ultrasound systems
Displayed in 1999 as a work-in-progress, Shimadzu's SDU-2200 will be shown as a finished product at this year's RSNA meeting. A new version of the SDU-450, the SDU-450 XL, will also be introduced.The SDU-2200 system includes 3-D, tissue harmonic imaging,
Displayed in 1999 as a work-in-progress, Shimadzu's SDU-2200 will be shown as a finished product at this year's RSNA meeting. A new version of the SDU-450, the SDU-450 XL, will also be introduced.
The SDU-2200 system includes 3-D, tissue harmonic imaging, and DICOM connectivity. Its proprietary digital electronics provide high-speed parallel processing, a quad digital beamformer, and high-level digital noise suppression. The SDU-2200 is a multipurpose, shared services system with applications that include cardiac, vascular, abdominal, ob/gyn, and urology.
The SDU-1200 uses the same console, operating system, and digital electronics as the SDU-2200. Applications are vascular, abdominal, ob/gyn, and urology, and its intended markets are outpatient centers and large private practices.
Both systems are semiautomatic and suitable for mobile applications.
The new SDU-450 XL includes an upgraded CPU with faster processing and enhanced applications software for ob/gyn, urology, emergency medicine, and family practice.
Shimadzu Ultrasound systems include Shimadzu's Truevision broadband probe technology with frequency versatility of 2 to 15 MHz.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
